Immunogenicity postvaccination (RSVpreF-elicited immune responses) was evaluated as antibody neutralization ... a single dose of the bivalent RSVpreF vaccine administered to ≥ 60-year-olds ...

Regulatory authorities in the US are investigating a possible link between the new Pfizer/BioNTech bivalent COVID-19 booster vaccine and strokes in people aged 65 or over, but still recommend the ...

For patients with hybrid immunity from prior infection, the adjusted VE of the bivalent vaccine was 62.2% (95% CI ... and the possibility of undetected infections due to antibody waning.

Taichengsi (Shanghai) Biomedical Co. Ltd. has described antibody-drug conjugates comprising an antibody covalently bound to a cytotoxic drug through a bivalent olefin linker optionally consisting of ...

The Moderna laboratories Tuesday reported that their two bivalent Omicron-targeting new messenger RNA (mRNA) technology booster vaccines (mRNA-1273.214 and mRNA-1273.222) have a superior antibody ...

US pharma giant Pfizer's new bivalent mRNA-based Covid booster vaccine has shown to be highly effective in reducing hospitalisation and deaths, particularly in vulnerable patients aged 65 years ...